These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 17895813)

  • 21. Efficacy of Intravitreal Injections of Triamcinolone Acetonide in a Rodent Model of Nonarteritic Anterior Ischemic Optic Neuropathy.
    Huang TL; Wen YT; Chang CH; Chang SW; Lin KH; Tsai RK
    Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):1878-84. PubMed ID: 27082303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of photodynamic therapy alone or combined with posterior subtenon triamcinolone acetonide or intravitreal bevacizumab on choroidal hypofluorescence by indocyanine green angiography.
    Hatta Y; Ishikawa K; Nishihara H; Ozawa S; Ito Y; Terasaki H
    Retina; 2010 Mar; 30(3):495-502. PubMed ID: 19996828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insight into 8 patients with nonarteritic anterior ischemic optic neuropathy following anti-VEGF injections.
    Mansour AM; Schwartz SG; Gregori NZ; Yehoshua Z; Freund KB; Dellatorre K; Aisenbrey S; Hosseini H; Huang JY; Bodla AA; Bhatti MT
    J Neuroophthalmol; 2012 Jun; 32(2):193. PubMed ID: 22549561
    [No Abstract]   [Full Text] [Related]  

  • 24. Intravitreal bevacizumab (avastin) injection alone or combined with triamcinolone versus macular photocoagulation as primary treatment of diabetic macular edema.
    Soheilian M; Ramezani A; Bijanzadeh B; Yaseri M; Ahmadieh H; Dehghan MH; Azarmina M; Moradian S; Tabatabaei H; Peyman GA
    Retina; 2007; 27(9):1187-95. PubMed ID: 18046223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravitreal bevacizumab vs intravitreal triamcinolone combined with macular laser grid for diffuse diabetic macular oedema.
    Forte R; Cennamo GL; Finelli M; Farese E; D'Amico G; Nicoletti G; de Crecchio G; Cennamo G
    Eye (Lond); 2010 Aug; 24(8):1325-30. PubMed ID: 20300127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bilateral simultaneous intravitreal injections in the office setting.
    Bakri SJ; Risco M; Edwards AO; Pulido JS
    Am J Ophthalmol; 2009 Jul; 148(1):66-9.e1. PubMed ID: 19403114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravitreal triamcinolone acetonide vs bevacizumab for treatment of macular oedema secondary to branch retinal vein occlusion.
    Cheng KC; Wu WC; Chen KJ
    Eye (Lond); 2009 Nov; 23(11):2023-33. PubMed ID: 19798117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravitreal triamcinolone after intravitreal bevacizumab for retinal vein occlusions.
    Jonas JB; Libondi T; Schlichtenbrede F; Schmidbauer M
    Acta Ophthalmol; 2010 Mar; 88(2):e24-5. PubMed ID: 19493250
    [No Abstract]   [Full Text] [Related]  

  • 29. Vitreous mediators after intravitreal bevacizumab or triamcinolone acetonide in eyes with proliferative diabetic retinopathy.
    Arimura N; Otsuka H; Yamakiri K; Sonoda Y; Nakao S; Noda Y; Hashiguchi T; Maruyama I; Sakamoto T
    Ophthalmology; 2009 May; 116(5):921-6. PubMed ID: 19410951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reflux after intravitreal injection of bevacizumab.
    Boon CJ; Crama N; Klevering BJ; van Kuijk FJ; Hoyng CB
    Ophthalmology; 2008 Jul; 115(7):1270; author reply 1271. PubMed ID: 18598829
    [No Abstract]   [Full Text] [Related]  

  • 31. Combined high-dose sub-tenon triamcinolone, intravitreal bevacizumab, and laser photocoagulation for refractory diabetic macular edema: a pilot study.
    Chan CK; Lai TY; Mohamed S; Lee VY; Liu DT; Li CL; Lam DS
    Retina; 2012 Apr; 32(4):672-8. PubMed ID: 22366900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravitreal VEGF levels in uveitis patients and treatment of uveitic macular oedema with intravitreal bevacizumab.
    Weiss K; Steinbrugger I; Weger M; Ardjomand N; Maier R; Wegscheider BJ; Wedrich A; El-Shabrawi Y
    Eye (Lond); 2009 Sep; 23(9):1812-8. PubMed ID: 19169227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Short-term complications of intravitreal injections of triamcinolone and bevacizumab.
    Jonas JB; Spandau UH; Schlichtenbrede F
    Eye (Lond); 2008 Apr; 22(4):590-1. PubMed ID: 18292795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Optic neuritis and optic ischemic neuropathy: the problem of differential diagnosis].
    Sheremet NL; Ronzina IA; Smirnova TV; Razumova IIu; Sheludchenko VM
    Vestn Oftalmol; 2012; 128(3):6-10. PubMed ID: 23120916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravitreal bevacizumab for choroidal neovascularization in toxoplasmosis.
    Guthoff R; Goebel W
    Acta Ophthalmol; 2009 Sep; 87(6):688-90. PubMed ID: 18631326
    [No Abstract]   [Full Text] [Related]  

  • 36. Response to: Combined treatment of intravitreal bevacizumab and intravitreal triamcinolone in patients with retinal vein occlusion by Schroff et al.
    Ehrlich R; Ciulla TA; Moss A; Harris A
    Graefes Arch Clin Exp Ophthalmol; 2011 Feb; 249(2):305. PubMed ID: 20352444
    [No Abstract]   [Full Text] [Related]  

  • 37. Single intravitreal injection of triamcinolone combined with bevacizumab for the treatment of diffuse diabetic macular oedema refractory to grid photocoagulation.
    Folgosa MS; Messias A; Takata C; Costa RA; Scott IU; Jorge R
    Acta Ophthalmol; 2010 Nov; 88(7):e297-8. PubMed ID: 19906082
    [No Abstract]   [Full Text] [Related]  

  • 38. Adalimumab-associated optic neuritis.
    Chung JH; Van Stavern GP; Frohman LP; Turbin RE
    J Neurol Sci; 2006 May; 244(1-2):133-6. PubMed ID: 16527311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravitreal Triamcinolone Acetonide Injection in a Rodent Model of Anterior Ischemic Optic Neuropathy.
    Pereira LS; Ávila MP; Salustiano LX; Paula AC; Arnhold E; McCulley TJ
    J Neuroophthalmol; 2018 Dec; 38(4):561-565. PubMed ID: 29521709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravitreal bevacizumab for idiopathic choroidal neovascularization after previous injection with posterior subtenon triamcinolone.
    Gomi F; Nishida K; Oshima Y; Sakaguchi H; Sawa M; Tsujikawa M; Tano Y
    Am J Ophthalmol; 2007 Mar; 143(3):507-10. PubMed ID: 17317397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.